Autoimmune Disease Diagnosis Market Overview, Key Players, Cost, Trend and Forecast to 2025

[Gauri Deshpande]

The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for autoimmune disease diagnosis due to their cost-effectiveness. On the other hand, complexities in manufacturing restraining the market.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=16...

The key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKUGROUP GMBH & CO. KG (Germany).

“The consumables & assay kits segment is anticipated to grow at the fastest growth rate during the forecast period.”

The autoimmune disease diagnosis market by product is categorized into consumables & assay kits and instruments.The consumables & assay kits segment is expected to register the highest CAGR during the forecast period. The growth of this segment is driven mainly by the increasing number of product launches/approvals, rising incidences of autoimmune diseases.

“The routine laboratory tests segment is estimated to grow at a rapid rate during the analysis period.”

Based on the test type, the autoimmune disease diagnosis market is segmented into routine laboratory tests, inflammatory markers, auto antibodies & immunologic tests, and other tests. The routine laboratory tests segment is expected to remain the fastest-growing segment of the global market during the autoimmune disease diagnosis period. The increasing number of regular health checkups, growing government initiatives to promote the importance of early disease diagnosis,are driving growth.

“Asia Pacific is estimated to register the highest CAGR during the study period.”

Geographically, the autoimmune disease diagnosis market is dominated by Europe and followed by North America in 2019. However,the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. The rising aging population, coupled with the massive demand for effective diagnosis of autoimmune diseases, will drive the market in the region over the forecast period.

Breakdown of Profiles of Primary Participants:

By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%
Research Coverage:

The report analyzes the autoimmune disease diagnosis market by product, test type, disease, end user, and region.Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use anyone,or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the services of the top players in the autoimmune disease diagnosis market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the autoimmune disease diagnosis market
Market Development: Detailed information about emerging markets.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market
Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name...

Table of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Growth Forecast
2.3 Market Breakdown And Data Triangulation

3 Executive Summary

4 Premium Insights
4.1 Attractive Market Opportunities In The Autoimmune Disease Diagnosis Market
4.2 Asia Pacific Market: By Disease
4.3 Autoimmune Disease Diagnosis Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence And Prevalence Of Autoimmune Diseases
5.2.1.2 Increasing Awareness About Autoimmune Diseases
5.2.1.3 Growth In The Number Of Research Activities On Autoimmune Diseases
5.2.2 Restraints
5.2.2.1 High Capital Requirements
5.2.3 Opportunities
5.2.3.1 Use Of Biosensors For Autoimmune Disease Diagnosis
5.2.4 Trends
5.2.4.1 Growth In The Number Of Reagent Rental Agreements

6 Autoimmune Disease Diagnosis Market, By Product
6.1 Introduction
6.2 Consumables & Assay Kits
6.2.1 Need For The Rapid Detection Of Autoimmune Diseases To Drive The Demand For Consumables And Assay Kits
6.3 Instruments
6.3.1 Instruments Segment To Record Significant Growth During The Forecast Period

7 Autoimmune Disease Diagnosis Market, By Test Type
7.1 Introduction
7.2 Routine Laboratory Tests
7.2.1 Rising Number Of Routine Health Check-Ups To Support Market Growth
7.3 Inflammatory Markers
7.3.1 Ability Of Inflammatory Markers To Detect Abnormalities Efficiently To Drive Their Demand
7.4 Autoantibodies And Immunologic Tests
7.4.1 Adoption Of Novel Immunology Tests To Drive Market Growth
7.5 Other Tests

8 Autoimmune Disease Diagnosis Market, By Disease
8.1 Introduction
8.2 Rheumatoid Arthritis
8.2.1 Increasing Incidence Of Rheumatoid Arthritis To Support Market Growth
8.3 Systemic Lupus Erythematosus
8.3.1 Rising Prevalence Of Lupus To Support Market Growth
8.4 Sjögren’s Syndrome
8.4.1 Rising Awareness Regarding Sjögren’s Syndrome To Support Market Growth
8.5 Thyroiditis
8.5.1 Rising Prevalence Of Thyroid Disorders To Drive Market Growth
8.6 Scleroderma
8.6.1 Increasing Incidence Of Skin Disorders To Drive Market Growth
8.7 Other Diseases

9 Autoimmune Disease Diagnosis Market, By End User
9.1 Introduction
9.2 Clinical Laboratories
9.2.1 Increasing Incidence Of Autoimmune Diseases To Increase Testing Volume In Clinical Laboratories
9.3 Hospitals
9.3.1 Increasing Government Initiatives To Provide Quality Treatment For Autoimmune Diseases To Support Market Growth
9.4 Other End Users

10 Autoimmune Disease Diagnosis Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 Rising Expenditure On Autoimmune Disease R&D To Drive Market Growth In The Us
10.2.2 Canada
10.2.2.1 Rising Prevalence Of Autoimmune Diseases To Support Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Rising Healthcare Expenditure To Drive Market Growth In Germany
10.3.2 Uk
10.3.2.1 Rising Prevalence Of Autoimmune Diseases To Drive Market Growth In The Uk
10.3.3 France
10.3.3.1 High Prevalence Of Multiple Sclerosis To Drive Market Growth In France
10.3.4 Italy
10.3.4.1 Increasing Life Science R&D Expenditure To Support Market Growth In Italy
10.3.5 Spain
10.3.5.1 Research Activities Conducted In The Country To Drive Market Growth In Spain
10.3.6 Rest Of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Outbreak Of Covid-19 To Hamper Market Growth During The Forecast Period
10.4.2 India
10.4.2.1 Development Of Antibody Tests To Support Market Growth In India
10.4.3 Japan
10.4.3.1 Rising Healthcare Expenditure To Support Market Growth In Japan
10.4.4 Australia
10.4.4.1 Rising Prevalence Of Autoimmune Diseases To Drive Market Growth In Australia
10.4.5 Rest Of Asia Pacific
10.5 Middle East & Africa
10.5.1 Rising Incidence Of Autoimmune Diseases To Support Market Growth In The Middle East And Africa
10.6 Latin America
10.6.1 High Prevalence Of Rheumatoid Arthritis To Support Market Growth In Latin America

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Product Launches (2017-2020)
11.3.2 Product Approvals (2017-2020)
11.3.3 Partnerships
11.3.4 Acquisitions (2017-2020)
11.3.5 Collaborations (2017-2020)
11.4 Competitive Leadership Mapping (2018)
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies

12 Company Profiles